Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Retrospective Analysis of Metronomic Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Versus Docetaxel and Cyclophosphamide (TC) as Adjuvant Treatment in Early Stage, Hormone Receptor Positive, HER2 Negative Breast Cancer.
Jung L, Miske A, Indorf A, Nelson K, Gadi VK, Banda K. Jung L, et al. Among authors: indorf a. Clin Breast Cancer. 2022 Apr;22(3):e310-e318. doi: 10.1016/j.clbc.2021.09.007. Epub 2021 Sep 22. Clin Breast Cancer. 2022. PMID: 34753632
Exemestane induced cholestatic liver injury - A case report.
Fritzsche D, Indorf A, Miske A, Banda K. Fritzsche D, et al. Among authors: indorf a. J Oncol Pharm Pract. 2021 Jun;27(4):1029-1032. doi: 10.1177/1078155220957726. Epub 2020 Sep 21. J Oncol Pharm Pract. 2021. PMID: 32951520
Antibody drug conjugates: Design implications for clinicians.
Pang S, Duong A, Siu C, Indorf A. Pang S, et al. Among authors: indorf a. J Oncol Pharm Pract. 2024 Apr 23:10781552241228827. doi: 10.1177/10781552241228827. Online ahead of print. J Oncol Pharm Pract. 2024. PMID: 38651308 Review.
13 results